EGFR signaling in breast cancer

Bad to the bone

John Foley, Nicole K. Nickerson, Seungyoon Nam, Kah Tan Allen, Jennifer L. Gilmore, Kenneth Nephew, David J. Riese

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. This family includes EGFR/ErbB1/HER1, ErbB2/HER2/Neu ErbB3/HER3, and ErbB4/HER4. For many years it was believed that EGFR plays a minor role in the development and progression of breast malignancies. However, recent findings have led investigators to revisit these beliefs. Here we will review these findings and propose roles that EGFR may play in breast malignancies. In particular, we will discuss the potential roles that EGFR may play in triple-negative tumors, resistance to endocrine therapies, maintenance of stem-like tumor cells, and bone metastasis. Thus, we will propose the contexts in which EGFR may be a therapeutic target.

Original languageEnglish
Pages (from-to)951-960
Number of pages10
JournalSeminars in Cell and Developmental Biology
Volume21
Issue number9
DOIs
StatePublished - Dec 2010

Fingerprint

Epidermal Growth Factor Receptor
Breast Neoplasms
Bone and Bones
Breast
Neoplasms
Neoplastic Stem Cells
Protein-Tyrosine Kinases
Maintenance
Research Personnel
Neoplasm Metastasis
Therapeutics

Keywords

  • Bone metastasis
  • Epidermal growth factor receptor
  • Resistance to endocrine therapy
  • Stem-like tumor cells
  • Triple-negative tumors

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

EGFR signaling in breast cancer : Bad to the bone. / Foley, John; Nickerson, Nicole K.; Nam, Seungyoon; Allen, Kah Tan; Gilmore, Jennifer L.; Nephew, Kenneth; Riese, David J.

In: Seminars in Cell and Developmental Biology, Vol. 21, No. 9, 12.2010, p. 951-960.

Research output: Contribution to journalArticle

Foley, John ; Nickerson, Nicole K. ; Nam, Seungyoon ; Allen, Kah Tan ; Gilmore, Jennifer L. ; Nephew, Kenneth ; Riese, David J. / EGFR signaling in breast cancer : Bad to the bone. In: Seminars in Cell and Developmental Biology. 2010 ; Vol. 21, No. 9. pp. 951-960.
@article{222b487633d349e486c93d4f7f3e3b5d,
title = "EGFR signaling in breast cancer: Bad to the bone",
abstract = "The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. This family includes EGFR/ErbB1/HER1, ErbB2/HER2/Neu ErbB3/HER3, and ErbB4/HER4. For many years it was believed that EGFR plays a minor role in the development and progression of breast malignancies. However, recent findings have led investigators to revisit these beliefs. Here we will review these findings and propose roles that EGFR may play in breast malignancies. In particular, we will discuss the potential roles that EGFR may play in triple-negative tumors, resistance to endocrine therapies, maintenance of stem-like tumor cells, and bone metastasis. Thus, we will propose the contexts in which EGFR may be a therapeutic target.",
keywords = "Bone metastasis, Epidermal growth factor receptor, Resistance to endocrine therapy, Stem-like tumor cells, Triple-negative tumors",
author = "John Foley and Nickerson, {Nicole K.} and Seungyoon Nam and Allen, {Kah Tan} and Gilmore, {Jennifer L.} and Kenneth Nephew and Riese, {David J.}",
year = "2010",
month = "12",
doi = "10.1016/j.semcdb.2010.08.009",
language = "English",
volume = "21",
pages = "951--960",
journal = "Seminars in Cell and Developmental Biology",
issn = "1084-9521",
publisher = "Academic Press Inc.",
number = "9",

}

TY - JOUR

T1 - EGFR signaling in breast cancer

T2 - Bad to the bone

AU - Foley, John

AU - Nickerson, Nicole K.

AU - Nam, Seungyoon

AU - Allen, Kah Tan

AU - Gilmore, Jennifer L.

AU - Nephew, Kenneth

AU - Riese, David J.

PY - 2010/12

Y1 - 2010/12

N2 - The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. This family includes EGFR/ErbB1/HER1, ErbB2/HER2/Neu ErbB3/HER3, and ErbB4/HER4. For many years it was believed that EGFR plays a minor role in the development and progression of breast malignancies. However, recent findings have led investigators to revisit these beliefs. Here we will review these findings and propose roles that EGFR may play in breast malignancies. In particular, we will discuss the potential roles that EGFR may play in triple-negative tumors, resistance to endocrine therapies, maintenance of stem-like tumor cells, and bone metastasis. Thus, we will propose the contexts in which EGFR may be a therapeutic target.

AB - The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. This family includes EGFR/ErbB1/HER1, ErbB2/HER2/Neu ErbB3/HER3, and ErbB4/HER4. For many years it was believed that EGFR plays a minor role in the development and progression of breast malignancies. However, recent findings have led investigators to revisit these beliefs. Here we will review these findings and propose roles that EGFR may play in breast malignancies. In particular, we will discuss the potential roles that EGFR may play in triple-negative tumors, resistance to endocrine therapies, maintenance of stem-like tumor cells, and bone metastasis. Thus, we will propose the contexts in which EGFR may be a therapeutic target.

KW - Bone metastasis

KW - Epidermal growth factor receptor

KW - Resistance to endocrine therapy

KW - Stem-like tumor cells

KW - Triple-negative tumors

UR - http://www.scopus.com/inward/record.url?scp=78449294111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449294111&partnerID=8YFLogxK

U2 - 10.1016/j.semcdb.2010.08.009

DO - 10.1016/j.semcdb.2010.08.009

M3 - Article

VL - 21

SP - 951

EP - 960

JO - Seminars in Cell and Developmental Biology

JF - Seminars in Cell and Developmental Biology

SN - 1084-9521

IS - 9

ER -